Morgan Stanley’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $714M | Buy |
1,356,103
+40,149
| +3% | +$22.5M | 0.04% | 435 |
|
|
2026
Q1 | $739M | Sell |
1,315,954
-237,777
| -15% | -$152M | 0.04% | 399 |
|
|
2025
Q4 | $1.05B | Sell |
1,553,731
-68,759
| -4% | -$46.8M | 0.06% | 274 |
|
|
2025
Q3 | $1.04B | Sell |
1,622,490
-40,836
| -2% | -$24.8M | 0.06% | 274 |
|
|
2025
Q2 | $892M | Buy |
1,663,326
+4,981
| +0.3% | +$2.38M | 0.06% | 310 |
|
|
2025
Q1 | $696M | Buy |
1,658,345
+25,306
| +2% | +$11M | 0.05% | 358 |
|
|
2024
Q4 | $675M | Buy |
1,633,039
+451,330
| +38% | +$198M | 0.05% | 373 |
|
|
2024
Q3 | $597M | Buy |
1,181,709
+40,749
| +4% | +$19.8M | 0.04% | 401 |
|
|
2024
Q2 | $556M | Sell |
1,140,960
-84,970
| -7% | -$42.7M | 0.04% | 406 |
|
|
2024
Q1 | $662M | Sell |
1,225,930
-964,030
| -44% | -$527M | 0.05% | 330 |
|
|
2023
Q4 | $1.22B | Buy |
2,189,960
+1,125,446
| +106% | +$528M | 0.05% | 328 |
|
|
2023
Q3 | $465M | Buy |
1,064,514
+48,095
| +5% | +$24M | 0.05% | 387 |
|
|
2023
Q2 | $510M | Buy |
1,016,419
+80,720
| +9% | +$38.7M | 0.05% | 362 |
|
|
2023
Q1 | $468M | Sell |
935,699
-50,533
| -5% | -$24.2M | 0.05% | 371 |
|
|
2022
Q4 | $402M | Buy |
986,232
+260,926
| +36% | +$101M | 0.05% | 411 |
|
|
2022
Q3 | $236M | Sell |
725,306
-30,313
| -4% | -$11.1M | 0.03% | 511 |
|
|
2022
Q2 | $265M | Buy |
755,619
+443,914
| +142% | +$181M | 0.03% | 489 |
|
|
2022
Q1 | $171M | Sell |
311,705
-126,994
| -29% | -$66.8M | 0.02% | 591 |
|
|
2021
Q4 | $289M | Buy |
438,699
+76,726
| +21% | +$48.2M | 0.04% | 440 |
|
|
2021
Q3 | $225M | Buy |
361,973
+24,313
| +7% | +$16.3M | 0.03% | 487 |
|
|
2021
Q2 | $213M | Buy |
337,660
+46,410
| +16% | +$25.6M | 0.03% | 524 |
|
|
2021
Q1 | $143M | Sell |
291,250
-94,020
| -24% | -$47.1M | 0.02% | 611 |
|
|
2020
Q4 | $193M | Buy |
385,270
+155,830
| +68% | +$69.7M | 0.03% | 488 |
|
|
2020
Q3 | $90.2M | Sell |
229,440
-1,943
| -0.8% | -$718K | 0.02% | 627 |
|
|
2020
Q2 | $76.4M | Sell |
231,383
-57,727
| -20% | -$16.7M | 0.02% | 649 |
|
|
2020
Q1 | $70M | Sell |
289,110
-4,862
| -2% | -$1.27M | 0.02% | 599 |
|
|
2019
Q4 | $76.8M | Sell |
293,972
-47,449
| -14% | -$12.5M | 0.02% | 718 |
|
|
2019
Q3 | $92.8M | Sell |
341,421
-4,565
| -1% | -$1.27M | 0.02% | 587 |
|
|
2019
Q2 | $95.3M | Buy |
345,986
+98,312
| +40% | +$24.2M | 0.03% | 570 |
|
|
2019
Q1 | $55.4M | Sell |
247,674
-186,223
| -43% | -$38.4M | 0.02% | 786 |
|
|
2018
Q4 | $80.7M | Sell |
433,897
-6,016
| -1% | -$1.23M | 0.02% | 601 |
|
|
2018
Q3 | $110M | Buy |
439,913
+57,828
| +15% | +$14M | 0.03% | 560 |
|
|
2018
Q2 | $83.3M | Buy |
382,085
+33,000
| +9% | +$6.8M | 0.02% | 660 |
|
|
2018
Q1 | $66.8M | Buy |
349,085
+37,108
| +12% | +$6.85M | 0.02% | 767 |
|
|
2017
Q4 | $48.8M | Sell |
311,977
-772
| -0.2% | -$122K | 0.01% | 972 |
|
|
2017
Q3 | $48.6M | Sell |
312,749
-196,937
| -39% | -$31.1M | 0.01% | 927 |
|
|
2017
Q2 | $82.3M | Buy |
509,686
+208,540
| +69% | +$33.9M | 0.02% | 655 |
|
|
2017
Q1 | $46.6M | Sell |
301,146
-258,105
| -46% | -$35.6M | 0.01% | 957 |
|
|
2016
Q4 | $65.6M | Buy |
559,251
+41,380
| +8% | +$4.72M | 0.02% | 723 |
|
|
2016
Q3 | $58.4M | Buy |
517,871
+58,850
| +13% | +$6.2M | 0.02% | 764 |
|
|
2016
Q2 | $42.6M | Buy |
459,021
+209,682
| +84% | +$18M | 0.02% | 889 |
|
|
2016
Q1 | $19.5M | Sell |
249,339
-23,333
| -9% | -$1.68M | 0.01% | 1321 |
|
|
2015
Q4 | $19.9M | Buy |
272,672
+79,704
| +41% | +$5.69M | 0.01% | 1397 |
|
|
2015
Q3 | $14.3M | Sell |
192,968
-37,045
| -16% | -$2.65M | 0.01% | 1651 |
|
|
2015
Q2 | $14.8M | Sell |
230,013
-89,117
| -28% | -$6.17M | 0.01% | 1756 |
|
|
2015
Q1 | $24.6M | Sell |
319,130
-13,538
| -4% | -$1.05M | 0.01% | 1292 |
|
|
2014
Q4 | $24.7M | Buy |
332,668
+141,428
| +74% | +$9.92M | 0.01% | 1304 |
|
|
2014
Q3 | $11.3M | Buy |
191,240
+1,200
| +0.6% | +$75.9K | ﹤0.01% | 1922 |
|
|
2014
Q2 | $12.7M | Buy |
190,040
+6,288
| +3% | +$400K | 0.01% | 1810 |
|
|
2014
Q1 | $11.2M | Sell |
183,752
-169,234
| -48% | -$10.1M | ﹤0.01% | 1871 |
|
|
2013
Q4 | $18.8M | Buy |
352,986
+204,804
| +138% | +$10.8M | 0.01% | 1396 |
|
|
2013
Q3 | $7.38M | Sell |
148,182
-9,840
| -6% | -$473K | ﹤0.01% | 2060 |
|
|
2013
Q2 | $7.09M | Buy |
+158,022
| New | +$6.9M | ﹤0.01% | 2000 |
|
Other funds holding IDXX
Morgan Stanley's IDXX Position: Q2 2026 in Review
Morgan Stanley increased its Idexx Laboratories (IDXX) stake by 3.1% in Q2 2026, buying an estimated $22.5M and bringing the position to 1,356,103 shares worth $714M. The position accounts for 0.04% of the portfolio, ranked #435.
Morgan Stanley first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.22B in Q4 2023. 1,293 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Morgan Stanley held 1,356,103 shares of Idexx Laboratories worth $714M as of Q2 2026.
- Morgan Stanley bought 40,149 Idexx Laboratories shares in Q2 2026, an estimated $22.5M.
- Idexx Laboratories made up 0.04% of Morgan Stanley's portfolio in Q2 2026, its #435 holding.
- Morgan Stanley first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's Idexx Laboratories position peaked at $1.22B in Q4 2023.
- 1,293 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.